These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37013781)

  • 21. Polycystic ovary syndrome.
    Goudas VT; Dumesic DA
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polycystic ovary syndrome].
    Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2000 May; 29(3):298-301. PubMed ID: 10804375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin and hyperandrogenism in women with polycystic ovary syndrome.
    Baptiste CG; Battista MC; Trottier A; Baillargeon JP
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):42-52. PubMed ID: 20036327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence variants in oxytocin pathway genes and preterm birth: a candidate gene association study.
    Kim J; Stirling KJ; Cooper ME; Ascoli M; Momany AM; McDonald EL; Ryckman KK; Rhea L; Schaa KL; Cosentino V; Gadow E; Saleme C; Shi M; Hallman M; Plunkett J; Teramo KA; Muglia LJ; Feenstra B; Geller F; Boyd HA; Melbye M; Marazita ML; Dagle JM; Murray JC
    BMC Med Genet; 2013 Jul; 14():77. PubMed ID: 23889750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome.
    Amin M; Horst N; Gragnoli C
    J Ovarian Res; 2023 Aug; 16(1):158. PubMed ID: 37563671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
    Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
    Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
    Li Q; Yan Z; Kuang Y; Zhou X; Jin L; He L; Sun X; Tao T; Wang L
    Hum Reprod; 2016 Sep; 31(9):2150-7. PubMed ID: 27354380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
    Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndrome.
    Bicer M; Alarslan P; Guler A; Demir I; Aslanipour B; Calan M
    J Endocrinol Invest; 2020 Mar; 43(3):305-313. PubMed ID: 31486991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
    Biyasheva A; Legro RS; Dunaif A; Urbanek M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2617-25. PubMed ID: 19351735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovarian syndrome.
    Trikudanathan S
    Med Clin North Am; 2015 Jan; 99(1):221-35. PubMed ID: 25456652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).
    Tan S; Scherag A; Janssen OE; Hahn S; Lahner H; Dietz T; Scherag S; Grallert H; Vogel CI; Kimmig R; Illig T; Mann K; Hebebrand J; Hinney A
    BMC Med Genet; 2010 Jan; 11():12. PubMed ID: 20092643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
    Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
    Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.